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ABSTRACT
Microfracture surgery may be applied to treat cartilage defects. During the procedure
the subchondral bone is penetrated, allowing bonemarrow-derivedmesenchymal stem
cells to migrate towards the defect site and form new cartilage tissue. Microfracture
surgery generally results in the formation of mechanically inferior fibrocartilage. As a
result, this technique offers only temporary clinical improvement. Tissue engineering
and regenerative medicine may improve the outcome of microfracture surgery. Filling
the subchondral defect with a biomaterial may provide a template for the formation
of new hyaline cartilage tissue. In this study, a systematic review and meta-analysis
were performed to assess the current evidence for the efficacy of cartilage regeneration
in preclinical models using acellular biomaterials implanted after marrow stimulating
techniques (microfracturing and subchondral drilling) compared to the natural healing
response of defects. The review aims to provide new insights into the most effective
biomaterials, to provide an overview of currently existing knowledge, and to identify
potential lacunae in current studies to direct future research. A comprehensive search
was systematically performed in PubMed and EMBASE (via OvidSP) using search
terms related to tissue engineering, cartilage and animals. Primary studies in which
acellular biomaterials were implanted in osteochondral defects in the knee or ankle
joint in healthy animals were included and study characteristics tabulated (283 studies
out of 6,688 studies found). For studies comparing non-treated empty defects to
defects containing implanted biomaterials and using semi-quantitative histology as
outcome measure, the risk of bias (135 studies) was assessed and outcome data were
collected for meta-analysis (151 studies). Random-effects meta-analyses were per-
formed, using cartilage regeneration as outcomemeasure on an absolute 0–100% scale.
Implantation of acellular biomaterials significantly improved cartilage regeneration
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by 15.6% compared to non-treated empty defect controls. The addition of biologics to
biomaterials significantly improved cartilage regeneration by 7.6% compared to control
biomaterials. No significant differences were found between biomaterials from natural
or synthetic origin or between scaffolds, hydrogels and blends.Nonoticeable differences
were found in outcome between animal models. The risk of bias assessment indicated
poor reporting for the majority of studies, impeding an assessment of the actual risk
of bias. In conclusion, implantation of biomaterials in osteochondral defects improves
cartilage regeneration compared to natural healing, which is further improved by the
incorporation of biologics.
Subjects Bioengineering, Orthopedics, Rheumatology, Translational Medicine
Keywords Regenerative medicine, Cartilage, Microfracture, Osteochondral, Biomaterials,
Scaffold, Cell-free
INTRODUCTION
Articular cartilage is a specialized tissue that covers joint surfaces and provides a low-friction
and load-bearing surface for a smooth motion of joints. The structure and function of the
tissue can be compromised by traumatic injuries and degenerative joint diseases. Due to
its avascular nature, damaged cartilage tissue does not heal spontaneously and it remains a
challenge to fully restore tissue function (Ahn et al., 2009; Cao et al., 2012).
The surgical options to treat patients with a localized cartilage defect are limited to
cartilage regeneration approaches such as autologous chondrocyte implantation and
microfracture surgery (Aulin et al., 2013; Bal et al., 2010). The latter strategy, also known
as bone marrow stimulation, is relatively simple, minimally invasive and inexpensive.
During this procedure the subchondral bone plate below the cartilage lesion is perforated
to initiate bleeding and induce a reparative response. The principle behind this regenerative
resurfacing strategy is the migration of non-differentiated bone marrow-derived
multipotent stem cells from the subchondral bone into the defect site leading to the
formation of new cartilage tissue (Buma et al., 2003; De Mulder et al., 2014; Erggelet et al.,
2009). Patients treatedwith bonemarrow stimulation generally show clinical improvements
up to 1.5–3 years after surgery. However, five years after surgery higher incidences of clinical
failures are observed (Hoemann et al., 2010; Van der Linden et al., 2013). The newly formed
tissue generally consists of fibrocartilage repair tissue rather than hyaline cartilage, has
limited filling of the defect, integrates poorly with the surrounding tissue and has inferior
mechanical properties compared to hyaline cartilage (Dai et al., 2014). Therefore, the need
for regeneration of more durable cartilage tissue persists.
Regenerative medicine and tissue engineering may offer promising alternatives and/or
additions to clinical strategies that aim to restore damaged cartilage tissue. The construction
of biomaterials and the incorporation of cells and biologics in these implants have been
widely investigated for this purpose. Biomaterials can be implanted in osteochondral
defects created by applyingmarrow stimulating techniques (microfracture and subchondral
drilling (Falah et al., 2010)) to guide and stimulate the formation of cartilage tissue (Seo
et al., 2014). During microfracture surgery, an arthroscopic awl is used to penetrate the
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subchondral bone, while with subchondral drilling a high speed drill is applied to penetrate
the trabecular bone. Different strategies have been applied including the implantation
of biomaterials with and without cells. Acellular biomaterials offer various advantageous
properties such as lack of donor-site morbidity, absence of cell culture costs, off the shelf
availability, fewer regulatory issues, and application of one-stage surgical procedures
(Brouwer et al., 2011; Efe et al., 2012). Many researchers have explored the approach of
implanting acellular biomaterials and investigated the use of various biomaterials in vivo,
such as natural (e.g., collagen (Breinan et al., 2000; Buma et al., 2003; Enea et al., 2013;
Wakitani et al., 1994), chitosan (Abarrategi et al., 2010; Bell et al., 2013; Guzman-Morales
et al., 2014; Hoemann et al., 2007), alginate (Igarashi et al., 2012; Mierisch et al., 2002;
Sukegawa et al., 2012) and hyaluronic acid (Aulin et al., 2013; Kayakabe et al., 2006;
Marmotti et al., 2012; Solchaga et al., 2000)) and synthetic polymers (e.g., polycaprolactone
(Christensen et al., 2012; Martinez-Diaz et al., 2010; Mrosek et al., 2010), polyvinyl alcohol
(Coburn et al., 2012; Holmes, Volz & Chvapil, 1975; Krych et al., 2013) and poly(lactic-co-
glycolic acid) (Athanasiou, Korvick & Schenck Jr, 1997; Chang et al., 2012; Cui, Wu & Hu,
2009; Fonseca et al., 2014)). To combine the advantageous properties of these materials,
multilayered biomaterials (e.g., β-tricalcium phosphate-hydroxyapatite/hyaluronate-
atelocollagen (Ahn et al., 2009), ceramic bovine bone-gelatin/gelatin-chondroitin sulfate-
sodium hyaluronate (Deng et al., 2012)), blends (e.g., poly(glycolic acid)-hyaluronic acid
(Erggelet et al., 2009) and type I collagen-hyaluronic acid-fibrinogen hydrogel (Lee et al.,
2012)) have been constructed. Biologics are natural factors that can be used to stimulate
tissue regeneration, e.g., by inducing proliferation and differentiation of cells. Biologics
such as growth factors of the transforming growth factor β (TGF-β) superfamily and others
have been incorporated in biomaterials to guide and stimulate the formation of hyaline
cartilage tissue (Richter, 2009). Moreover, it has been reported that the animal model of
choice may have a significant impact on study outcome of articular cartilage regeneration
(Reinholz et al., 2004). Currently, there is no systematic overview of the current literature
assessing the effect of various parameters (e.g., applied biomaterials, incorporated biologics
and animal models) on cartilage regeneration.
The aim of this systematic review and meta-analysis is to assess all current evidence for
the efficacy of articular cartilage regeneration using acellular biomaterials implanted in
the knee and ankle joint after microfracture and subchondral drilling in animal models.
Additionally, we strive to provide transparency on the quality of performed in vivo studies,
in order to aid the design of future animal experiments and clinical trials. We provide
a systematic and unbiased overview of the current literature addressing regeneration of
articular cartilage using a wide range of acellular biomaterials containing various biological
cues (as illustrated in Fig. 1). Results of semi-quantitative histological scoring systems are
used as a quantitative outcome parameter for outcome assessment of cartilage regeneration.
Although microfracture surgery and subchondral drilling strive to stimulate cartilage and
osteochondral regeneration, respectively, both are generalized in this study as cartilage
regeneration. Moreover, the evaluation of different subgroups (natural and synthetic
origin of the biomaterials, structure of the materials (scaffolds vs. hydrogels), incorporated
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Figure 1 Illustration of cartilage regeneration by implantation of biomaterials after bone marrow
stimulation. The implanted biomaterials provide a template to guide cartilage regeneration by bone mar-
row derived mesenchymal stem cells.
biological cues, and animal models) was included to gain insights in which parameters
affect cartilage regeneration and to what extent.
MATERIALS AND METHODS
Search strategy
To identify relevant peer-reviewed articles, a comprehensive search of the literature using
PubMed and EMBASE (via OvidSP) was conducted, using the methods defined byDe Vries
et al. (2012) and Leenaars et al. (2012). The last search date was April 3rd 2015. In both
databases, a tissue engineering search component developed by Sloff et al. (2014), consisting
of equivalents for tissue engineering (e.g., tissue regeneration, regenerative medicine, bio-
engineering or biomatrices), was combined with a cartilage search component, consisting
of equivalents for cartilage and cartilage-related surgeries (e.g., chondral, chondrogenic,
surgery, microfracturing or implants). The search components were constructed using
MeSH terms (PubMed) and EMTREE terms (EMBASE) and additional free-text words
from titles or abstracts ([tiab] or ti,ab). The obtained tissue engineering-related and
cartilage-related results were filtered for animal studies using previously described animal
search filters (De Vries et al., 2011; Hooijmans et al., 2010). The complete search strategy is
attached in Supplemental Information 1. No language restrictions were used.
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Study selection
References from the PubMed and EMBASE search strategies were combined and duplicates
were manually removed from EndNote, with the preference of PubMed over EMBASE.
All screening phases were performed by two independent reviewers (MP and VG) and
reported according to the ‘‘Preferred Reporting Items for Systematic Reviews and Meta-
Analysis’’ (PRISMA) guidelines (Higgins & Green, 2011). References were first screened
based on title and were excluded based on the following criteria: (1) titles showed no
relevance to regeneration of articular (hyaline) cartilage, (2) it was specifically stated
in the title that the conducted experiment was an in vitro study only, (3) osteoarthritis
animal models were used, (4) only ex vivo studies were performed, and (5) deceased
animals were used. In case of doubt or disagreement, references were included for further
screening. The second screening phase consisted of a title/abstract screening in Early
Review Organizing Software (EROS, Institute of Clinical Effectiveness and Health Policy,
Buenos Aires, Argentina; www.eros-systematic-review.org). References were included
based on the following inclusion criteria: (1) primary study, (2) animal model, (3) bone
marrow stimulation by microfracturing or creation of an osteochondral defect, and (4)
biomaterial implantation. Articles were only excluded when it was specifically stated in the
abstract that the study was performed without healthy animals or acellular biomaterials,
or if biomaterials were not implanted in the knee or ankle joint. Articles were not excluded
in case important information in the abstract was missing. These articles were assessed
in the full-text screening phase. For the full-text screening, articles were included if
they met all of the following inclusion criteria: (1) primary study, (2) animal model,
(3) healthy animals, (4) articular cartilage regeneration, (5) knee or ankle joint, (6) bone
marrow stimulation by microfracturing or creation of an osteochondral defect, and (7)
implantation of an acellular biomaterial. In general, if results of the two reviewers were
different, articles were discussed until consensus was reached. In case of double publication,
one of the studies was removed. During the screening phase, no selectionwasmade based on
publication language. The risk of bias assessment and meta-analysis was applied to studies
with a comparison between a non-treated empty defect control and biomaterial implan-
tation, and with semi-quantitative histological scoring system results as outcome data.
Study characteristics
From the studies included after the full-text screening, the following details were obtained:
general information (author and year of publication), animal characteristics (species, strain,
sex, age, weight and the number of animals), information related to the surgical defect
(size, depth and location), experimental conditions, biomaterial, biologics, evaluation time
points and all outcome measures used, i.e., macroscopic evaluation, semi-quantitative
macroscopic evaluation, histology, immunohistochemistry, semi-quantitative histological
scoring, and biomechanical tests. Data from semi-quantitative histological scorings
were used in the meta-analysis (described in ‘Analysis preparations and meta-analysis’).
Histological scoring systems applied in different studies consisted of scoring parameters like
cell morphology, Safranin-O staining, integrity of surface, thickness, surface of area filled
with cells, chondrocyte clustering, degenerative changes, restoration of the subchondral
bone and integrity.
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Risk of bias assessment
A risk of bias analysis was performed to assess the methodological quality of the studies
included in the meta-analysis, using an adapted version of the risk of bias tool described by
Hooijmans et al. (2014) (for all included studies containing a ‘non-treated empty defect’ as
control group and studies using semi-quantitative histological scoring systems as outcome
measure). A flowchart was constructed (Supplemental Information 2) to score for selection,
performance, detection and attrition bias, where the scores ‘−’, ‘?’ and ‘+’ indicate a low,
unknown and high risk of bias, respectively. The questions addressed are specified in the
Supplemental Information 2. Articles were scored independently by MP and VG, and if
the results of the two reviewers were different, results were discussed until consensus was
reached. All articles written in Chinese (16 studies) were excluded from the risk of bias
assessment only, due to limited resources to independently translate these articles by two
native Chinese speakers. However, the data of these studies were extracted and used in the
meta-analysis.
Analysis preparations and meta-analysis
Analysis preparations
The statistical analyses were restricted to those studies containing the outcome measure
semi-quantitative histology, making a comparison between a ‘non-treated empty defect’ as
control group and implanted biomaterials as experimental group. Data (mean, standard
deviation (SD) and number of animals) of the control and experimental group were
extracted from the studies, for all available time points. When results were not given
numerically, but depicted graphically, the mean and SD were measured using ImageJ
(1.46r, National Institutes of Health USA). For studies presenting results in boxplots, the
mean and standard deviation were recalculated from the median, range and the sample
size according the method described by Hozo, Djulbegovic & Hozo (2005). When data were
described by a mean and confidence interval (CI), the CI was recalculated to a standard
deviation by the following equation: standard deviation=√N×upper limit−lower limit3.92 for a
95%CI (Higgins & Green, 2011). For some studies, data were unclear and assumptions were
made, which are listed in Supplemental Information 3. To compare studies with different
histological score system scales, means and standard deviations were converted to a 100%
scale by dividing the result by the maximum achievable histological score and multiplying
by 100%. In case of missing or unclear data, authors were e-mailed to retrieve the data.
When data could not be obtained, these studies were excluded from the meta-analysis
(reasons for exclusion are also given in Supplemental Information 3). Results of studies
with several experimental groups were combined, following the approach described in the
Cochrane Handbook, table 7.7 (Higgins & Green, 2011). The same approach was followed
to combine results of different animals on several time points in the same group in the
same study. One study (Hamanishi et al., 2013) had an SD of zero, which caused problems
in the analyses. Therefore, the SD was changed to 4.29, equal to the SD of the experimental
group of the same study at the same time point. The resulting data were used to calculate
the treatment effect and corresponding standard error (SE) per study.
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Meta-analysis
The following main research question was assessed: Does an overall beneficial effect exist
of implanting acellular biomaterials in osteochondral defects compared to non-treated
empty defects?
First, in order to select the appropriate statistical random-effects meta-analysis model,
we compared a univariate approach to the bivariate approach. In the bivariate approach,
separate outcomes for control and experimental group were used with their respective SEs.
The correlation between these two outcomes was modeled with a compound symmetry
covariance matrix, as this resulted in a much lower Akaike Information Criterion value
than the use of an unstructured covariance matrix. Results were compared with those of
the univariate approach, based on the treatment effect and SE per study. Results of the
univariate and bivariate approaches were very similar and we therefore proceeded with the
univariate approach, when applicable in combination with likelihood ratio tests.
Restricted to the experimental groups, the following sub-questions were addressed
to evaluate whether the treatment effect depended on specific variables: (1) Is there a
difference between the use of natural and synthetic biomaterials?; (2) Does the structure of
the biomaterials affect cartilage regeneration?; (3) Do differences among various material
subgroups exist?; (4) Does incorporation of biologics have a beneficial effect on cartilage
regeneration compared to control biomaterials?; (5) Do differences among subgroups of
biologics exist?; (6)Do different animalmodels result in variations in cartilage regeneration?
Results are shown as % cartilage regeneration (95% CI: [lower CI, upper CI]. Some studies
have more than one experimental group. Therefore, the total number of studies and
number of experimental groups (no. of studies/groups) are provided.
Sensitivity analyses were performed to evaluate the effect of time (e.g., all time points,
short (≤8 weeks), long time points (>8 weeks), or the maximum time point), outliers
(excluding consecutively the studies with the 10% highest/lowest pooled SD, and studies
with the 10% highest/lowest SE), implant location, bone marrow stimulating technique
applied (microfracturing vs. subchondral drilling), language (excluding studies reported in
Chinese as the risk of bias of these studies was not assessed), and excluding studies where
assumptions had to be made. Based on a pilot analysis, data of all time points were used
for subgroup analyses. Subgroup analyses were only performed for subgroups consisting
of more than two groups.
The statistical analyses were performed with SAS/STAT R© software version 9.2 for
Windows (SAS Institute Inc., Cary, NC, USA). The funnel plot shows the overall outcome
of the pooled effect size of each study. I 2 was used as a measure of heterogeneity. The
forest plot was created with ReviewManager (RevMan, Version 5.3, 2014; The Cochrane
Collaboration, The Nordic Cochrane Centre, Copenhagen, Denmark).
RESULTS
Search and study inclusion
The searches conducted in PubMed and EMBASE (Supplemental Information 1) resulted in
4,401 and 5,986 studies, respectively, leaving 6,688 studies after removal of duplicates. These
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Figure 2 PRISMA (Preferred Reporting Items for Systematic Reviews andMeta-analysis) flowchart of
the systematic search of literature.
studies were screened by title and title/abstract, which resulted in 1,088 included studies
after the title screening and 517 included studies after the title/abstract screening. Screening
articles by full-text and subsequently selection for studies with empty defect controls as well
as semi-quantitative histology as outcome measure resulted in 283 included studies after
full-text assessment, of which 151 and 135 articles could be used for the meta-analysis and
risk of bias assessment, respectively (Fig. 2). The studies from Xie et al. (2014), Yao, Ma &
Zhang (2000) and Zhou & Yu (2014) could not be retrieved as a full text and these studies
were therefore excluded. An overview of all included studies after full-text assessment as
well as studies included for the risk of bias assessment and meta-analysis is provided in
Supplemental Information 3. All references and abbreviations can be found in Supplemental
Information 4. In this table, remarks are provided related to exclusion reasons for risk
of bias assessment and meta-analysis (e.g., duplicate publication and incomplete data).
Assumptions made for certain studies are also stated in this table.
Study characteristics
The study characteristics (Supplemental Information 3) clearly show substantial variation
among studies. A wide range of animal species was used, from small (rat and rabbit) to
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larger animal models (dog, minipig, goat, pig, sheep and horse). A large variation was
observed between the ages of animals (e.g., the age of rabbits ranged from 6 weeks to >2
years). Often ages were not described or specified specifically (e.g., as adult or mature).
Generally, the animals were older (range of years) in large animal models compared to
animals used in small animal models (range of months). The defects were created at
different locations in the knee joint, such as the trochlea, condyle (medial and lateral),
femur and intercondylar fossa. In addition, a large variation was found in the dimensions
of the prepared defects, e.g., the dimensions of the defects created in rabbits ranged from
4–7 mm in diameter and 0.8–9 mm in depth. Microfracture surgery and subchondral
drilling was performed in 25 and 258 studies, respectively. The implanted biomaterials
were of natural or synthetic origin or combinations thereof, and consisted of single-layered
or multilayered implants or blends thereof. Implants were constructed from a wide range
of materials or combinations thereof, such as collagen, chitosan, hyaluronic acid, alginate,
fibrin, hydroxyapatite, poly(lactic-co-glycolic acid), polycaprolactone, poly(glycolic acid)
and poly(ethylene glycol), and used in different states: scaffolds, hydrogels, or hybrid
mixtures of both. Various biological cues were incorporated in the biomaterials prior to
implantation or administered afterwards by injection into the knee joint, mostly growth
factors of the TGF-β superfamily such as bone morphogenetic protein 2 (BMP-2) and
TGF-β1, but also fibroblast growth factor (FGF) and platelet-rich plasma (PRP). The
maximum follow-up time was 1 year, but studies mainly investigated relatively short-term
effects of implanted biomaterials on cartilage regeneration (up to 6 months).
Risk of bias assessment
A risk of bias assessment was performed to assess risks of bias (selection, performance bias,
detection and attrition bias) in studies included for the meta-analysis (Fig. 3). An overview
of all scores per individual study is provided in Supplemental Information 6.
The risk of bias assessment showed that details with respect to the randomization
method were not provided (Q1). It was often described that animals were randomized
across different groups without describing the method of randomization, thereby limiting
assessment of the adequacy of randomization and therefore the actual risk of selection
bias. Another notable observation from the experimental designs studied was that only
in a limited number of studies it was described that power calculations were performed,
whereas sufficient power in animal experiments is a requirement for performing adequate
studies. The actual power analyses were never provided in the studies. Due to a lack of
information, it was also difficult to assess possible bias by differences in implantation
sites (with differences in load-bearing conditions, Q2.1) and differences between groups
related to the age, sex and weight of the animals at the start of the experiment (Q2.2).
Generally, baseline characteristics of animals prior to implantation of biomaterials (e.g.,
some animals received additional surgery related to harvesting of cells for biomaterials
combined with cells, Q2.3) were similar. When implanting biomaterials, no details were
described on blinding different biomaterials (Q3). Blinding of the empty defect and
biomaterial conditions should be performed to limit bias. However, blinding between the
empty defect and biomaterial group is impossible in case only one biomaterial is implanted.
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Figure 3 Risk of bias of all included studies in the meta-analysis. The green, orange and red colors
depict the percentages of studies with low, unknown or high risk of bias of the total number of assessed
studies. The risk of bias assessment indicated a general lack of details regarding the experimental setup,
as indicated by the orange bars. The green bars represent a low risk of bias, mainly for the difference be-
tween groups at the moment of surgical intervention and addressing incomplete outcome data. High risk
of bias was infrequently scored, as indicated by the red bars. Q4–Q6 are not depicted in the graph, but are
described in Supplemental Information 6.
More than half of the studies conducted blinded outcome assessment while performing the
histological scoring, resulting in low risk of detection bias, whereas the other studies had an
unknown risk (Q7). For most studies, no incomplete outcome data were described/found,
resulting in low risk of attrition bias. For some studies, dropouts were described/found,
resulting in differences between groups and high risk of bias (Q8). Overall, the risk of bias
analysis generally revealed poor reporting of the experimental design for the majority of
the studies, impeding an assessment of the actual risk of bias.
Data synthesis
For an overview of the meta-analysis and results obtained, see Table 1. The histological
scores of defects implanted with biomaterials and non-treated empty defects are presented
as a percentage on a 100% scale, where 0% and 100% indicate poor and perfect cartilage
regeneration, respectively. Data are presented as the effect (%) with 95% CI.
Overall effect biomaterial implantation
The meta-analysis indicates a significant improvement of cartilage regeneration using
acellular biomaterials implanted after applying marrow stimulating techniques compared
to non-treated empty defects (15.6% (95% CI [12.6, 18.6], p< 0.0001). The forest plot
(Supplemental Information 7) depicts the outcome effect of each individual study. In 73
studies cartilage regeneration significantly improved by the incorporation of biomaterials.
In 48 studies no effect was found, whereas in only six studies a negative effect on cartilage
regeneration was observed. A similar significant effect was observed taking into account
the maximum follow-up only (16.3% [13.1, 19.6], p< 0.0001). Also for short and long
term follow-up cartilage regeneration was significantly improved (≤8 weeks: 12.5% [9.3,
15.7],>8 weeks: 17.1% [13.9, 20.2]). No notable differences in cartilage regeneration were
found between the results based on the maximum follow-up time per study versus those
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Table 1 Overview of the meta-analysis results for the main research question assessing the overall beneficial effect of implanting acellular bio-
materials in osteochondral defects compared to non-treated empty defects and sub-questions evaluating the effect of specific variables on the
treatment effect. The total number of studies and number of experimental groups included in the meta-analysis are shown (some studies have>1
experimental group, no. of studies/groups). The quality of cartilage regeneration is presented on a 100% scale, where 100% represents the maximum
achievable histological score and thus the best cartilage regeneration. Implantation of biomaterials significantly improved cartilage regeneration
compared to non-treated empty defects, which was further improved by the incorporation of biologics. No significant differences were found be-
tween natural and synthetic materials, between the various material subgroups, and between the biomaterial structures (hydrogels versus scaffolds
versus blends), and between animal species.
Meta-analysis No. of
studies/groups
Subgroups Cartilage regeneration
(% (95%CI))
Mean difference
(% (95% CI)) p-value
127/400 Biomaterial 53.6 [50.7, 56.6] 15.6 [12.6, 18.6]
1. Overall effect
127/247 Empty defect 38.1 [35.1, 41.0] p< 0.0001
76/222 Natural 53.0 [49.3, 56.6] −0.73 [−6.5, 5.0]
2. Origin materials
39/137 Synthetic 53.7 [48.8, 58.7] p= 0.887
20/68 Collagen 49.5 [41.1, 57.8]
6/17 Chitosan 57.5 [40.8, 74.2]
5/11 Hyaluronic acid 47.9 [31.7, 64.1]
5/16 Alginate 63.0 [46.9, 79.00]
3/10 Fibrin 55.3 [34.4, 76.3]
5/11 Bone 51.2 [35.2, 67.2]
15/52 PLGA 58.5 [49.0, 68.0]
3. Material subgroups
6/21 PAMPS-PDMAAm DN 47.9 [31.7, 64.1]
p= 0.804
78/258 Scaffolds 53.1 [49.5, 56.7]
41/127 Hydrogels 54.2 [49.4, 59.1]4. Scaffold structure
7/17 Blends 55.7 [42.0, 69.3]
p= 0.973
113/291 No biologicals 51.7 [48.6, 54.9] 7.56 [2.1, 13.0]
5. Biologicals
35/109 Biologicals 59.3 [54.0, 64.6] p= 0.007
9/35 BMP 56.6 [−6.3, 119.6]
5/20 FGF 51.8 [−43.9, 147.4]
8/14 PRP 55.9 [−20.9, 132.8]6. Biological cues
6/16 TGF 60.2 [−7.5, 128.0]
p= 0.780
3/5 Dogs ED: 31.9 [14.5, 49.4]; B: 50.6 [33.0, 68.2] 18.7 [−0.0, 37.3]
5/13 Goats ED: 58.5 [43.4, 73.7]; B: 61.6 [47.6, 75.6] 3.1 [−13.2, 19.4]
1/3 Macaques ED: 12.2 [−18.2, 42.6]; B: 6.8 [−23.3, 37.0] −5.4 [−37.6, 26.8]
10/20 Minipigs ED: 42.4 [32.4, 52.4]; B: 56.1 [46.3, 66.0] 13.6 [3.1, 24.1]
94/333 Rabbits ED: 37.7 [34.2, 41.1]; B: 52.5 [49.0, 55.9] 14.8 [11.1, 18.5]
13/23 Sheep ED: 35.3 [26.4, 44.3]; B: 61.3 [52.7, 70.0] 26.0 [16.3, 35.7]
7. Animal models
p= 0.348
Notes.
ED, Empty defect; B, Biomaterials.
based on all time points per study. Therefore, further subgroup analyses were made using
results from all time points together.
Natural and synthetic materials
The subgroup analysis assessing cartilage regeneration using materials of different origin,
natural and synthetic, indicated no significant differences (p= 0.887) between natural
(53.0% [49.31, 56.63]) and synthetic materials (53.7% [48.75, 58.65]).
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Dividing the group of materials into subgroups allows comparison of cartilage
regeneration using different biomaterials. The following subgroups were studied: (1)
collagen, (2) chitosan, (3) hyaluronic acid–based biomaterials), (4) alginate, (5) fibrin), (6)
bone material-based, (7) PLGA, and (8) PAMPS-PDMAAm DN hydrogel. No significant
differences between the biomaterial subgroups were found (Table 1).
Material structure
Materials were divided in three groups based on their structure: (1) scaffolds, (2) hydrogels,
and (3) blends. Cartilage regeneration was similar after use of scaffolds (53.1% [49.53,
56.74]), hydrogels (54.2% [49.39, 59.07]) and blends (55.7% [42.0, 69.3), p= 0.973.
Biologics
Incorporation of biologics in the biomaterials resulted in a statistically significant
improvement in cartilage regeneration of 7.6% [2.1, 13.0], p= 0.007, compared to the
implantation of control biomaterials. Including only those studies with a direct comparison
between control biomaterials and biomaterials loaded with biologics resulted in an
improved cartilage regeneration of 14.6% [5.9, 23.4], p= 0.003. Comparing various
biological cues including BMP, FGF, PRP and TGF indicated no significant differences in
improvement of cartilage regeneration between these biologics.
Animal models
Evaluation of the animalmodels used showed no significant differences (p= 0.348) between
the effects of biomaterials implanted in dogs, goats, macaques, minipigs, pigs, rabbits, rats
or sheep (Table 1).
Sensitivity analyses
Sensitivity analyses were performed to assess the robustness of the meta-analysis with
respect to the overall effect. The sensitivity analyses indicated that exclusion of studies with
assumptions and studies written in Chinese (no risk of bias assessment analyzed) had no
effect on the estimated difference in biomaterial regeneration. Moreover, including only
studies with SDs or SEs in the 10–90% range did not notably change of the overall outcome
effect. In a post-hoc analysis, we investigated cartilage regeneration using biomaterials
implanted at different locations including condyles, femur, intercondylar fossa and the
trochlea. No differences were found comparing these implant sites (p= 0.143). In another
post-hoc analysis, we compared cartilage regeneration of empty defects or defects filled
with biomaterials after applying microfracturing or subchondral drilling. For empty defects
(p= 0.152) and biomaterial implants (p= 0.063) no significant differences between the
two bone marrow stimulating techniques were found.
Publication bias
A funnel plot (Fig. 4) was prepared for all included studies to analyze the overall comparison
between acellular biomaterials and non-treated empty defect controls. No extensive
asymmetry was observed, indicating an absence of considerable publication bias.
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Figure 4 Funnel plot of included studies to assess the overall effect of the implantation of acellular
biomaterials compared to non-treated empty defect controls. The figure indicates no substantial asym-
metry.
DISCUSSION
The regeneration of damaged cartilage has been widely investigated using preclinical
models. However, the efficacy of cartilage regeneration using implantation of acellular
biomaterials has never been assessed using a systematic review and meta-analysis. This
systematic review aimed (a) to provide an overview of currently existing knowledge and
identify knowledge gaps, (b) to provide transparency on the quality of performed in vivo
studies, and (c) to aid the design of future animal studies and clinical trials. The results
could provide insight in strategies for future (pre) clinical research related to biomaterial
properties, incorporation of biologics, choice of a suitable animal model, and their effects
on cartilage regeneration.
The general findings of this systematic review andmeta-analysis are that the implantation
of biomaterials improves cartilage regeneration compared to non-treated osteochondral
defects by 16% (95%CI). There were only six out of 151 studies that showed a negative effect
of biomaterial implantation on cartilage regeneration. In 48 studies no significant effect on
cartilage regeneration was found. For those studies with improved cartilage regeneration
(73 studies), clinical studies will have to confirm the beneficial effect of implantation
of biomaterials on cartilage regeneration in human patients. Filardo et al. described the
implantation of an osteochondral biomimetic scaffold consisting of a type I collagen
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cartilage-like layer, a type I collagen/hydroxyapatite intermediate layer, and a mineralized
blend of type I collagen and hydroxyapatite as a subchondral bone compartment, to
treat patients with osteochondritis dissecans. For these patients, clinical scores improved
significantly after the first two years and evaluation by MRI indicated good defect filling
and implant integration, but also heterogeneous tissue regeneration and changes of the
subchondral bone (Filardo et al., 2013). In two studies included in this systematic review
and meta-analysis, this osteochondral biomimetic scaffold was also implanted in sheep.
Cartilage regeneration after six months was 81.8%± 8.9% (empty defect: 23.2%± 20.7%)
and 81.2% ± 5.1% (empty defect: 23.4% ± 6.7%). A direct comparison between the
degree of cartilage regeneration described in the preclinical studies and clinical study is
not possible since no histological results were described in the clinical study. In addition,
outcome measures used in preclinical studies may not predict the clinical outcome.
For example, a randomized controlled clinical trial with BST-CarGel, a chitosan-based
medical device, showed greater lesion filling and superior repair tissue quality compared to
bone marrow stimulation after twelve months implantation, but without notable clinical
differences related to pain, stiffness and physical function between both groups (Stanish
et al., 2013). A remarkable observation is the difference in follow-up between the studies,
which may explain the good histological scores in the preclinical studies after six months
and heterogeneous tissue regeneration and changes of the subchondral bone after two
years in human patients. In general, clinical studies demonstrated improved cartilage
regeneration by the implantation of biomaterials after bone marrow stimulation, but there
is still room for improvement regarding clinical outcome and tissue quality.
The only subgroup analysis that showed a statistically significant result between the
groups was between control biomaterials and biomaterials loaded with biologics. In future
clinical studies assessment of the beneficial properties of implanting biomaterials loaded
with biologics is of interest, since a significant improvement of 8% (95% CI) compared to
control biomaterials was found and even 14.6% when using studies that directly compared
biomaterials with and without biologics. We were not able to perform analyses for the
effect of the concentration or subtype of the growth factors due to the small size of these
subgroups, although these factors may have a large effect on the outcome. In the study
by Ishii et al. (2007) a positive effect of FGF-2 was observed by the addition of at least 183
ng to the biomaterials, while Maehara et al. (2010) showed significant improvements of
impregnating biomaterials in 10 µg/ml and not for 100 µg/ml FGF-2. Loading biomaterials
with different BMPs including BMP-2 (Aulin et al., 2013; Reyes et al., 2012; Reyes et al.,
2014; Reyes et al., 2013; Tamai et al., 2005) and BMP-7 (Mori et al., 2013), or TGF subtypes
including TGF-β (Mierisch et al., 2002) and TGF-β1 (Reyes et al., 2012; Reyes et al., 2014),
resulted in significantly improved cartilage regeneration. However, for clinical application
of these medical devices, one should take safety of the products into account as side effects
of TGF-β in a joint environment, including fibrosis and osteophyte formation, have been
described (Blaney Davidson, Van der Kraan & Van den Berg, 2007) and patients suffered
from major complications after spinal surgery and implantation of high concentrations of
BMP/INFUSE (Epstein, 2013).
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The study characteristics of all included studies were tabulated to provide an extensive
overview of the available literature. Besides the internal validity of the studies, the
generalizability (external validity) of the study results is of great importance. The latter
is affected by factors related to the animal model (species, strain, weight, age, and sex),
surgery (location and size of the defect) and follow-up, resulting in heterogeneity between
studies. This was also indicated by the relatively high level of heterogeneity (I 2) for the
main meta-analysis (99.4% [99.4, 99.4]), and the heterogeneity was almost similar for
subgroup analyses. We chose to include only healthy animals receiving biomaterials.
The screened studies also contained osteoarthritis models that were not included, which
may be relevant for future applications to treat patients with osteoarthritis. Therefore,
results from this systematic review and meta-analysis may be different compared to results
found for osteoarthritis models and future clinical studies with osteoarthritis patients.
We assumed that in order to assess the effect of implanted biomaterials on cartilage
regeneration, reduction of the influence of confounding parameters would aid the validity
of the results and conclusions. In this study, the meta-analysis included all available
data of the effect of implanting biomaterials after applying bone marrow stimulating
techniques (microfracture and subchondral drilling) compared to empty defects on
cartilage regeneration. During microfracture surgery the subchondral bone is penetrated
using an arthroscopic awl, whereas during subchondral drilling the trabecular bone is
penetrated using a high speed drill, which may result in thermal necrosis (Falah et al.,
2010). Remarkably, more studies applied subchondral drilling (258 studies) compared to
microfracture surgery (25 studies), while microfracture surgery was developed to overcome
problems associated with thermal necrosis from subchondral drilling in the treatment of
human patients (Kane et al., 2013). We did perform a post-hoc meta-analysis to investigate
differences in cartilage regeneration after applying both marrow stimulating techniques
and subsequent implantation of biomaterials, which resulted in no significant differences
between microfracturing and subchondral drilling. A reason for the larger number of
animal studies performing subchondral drilling compared to microfracture surgery may be
the ease to perform subchondral drilling over microfracture surgery in animals. Although
in the included studies various implant locations (i.e., trochlea and condyles) were used, we
grouped the results in the meta-analysis. A post-hoc subgroup analysis was performed to
compare defect locations, but no overall significant differences were found for biomaterials
implanted at different implant locations. Our analysis did not confirm a finding of Chen et
al. (2013) showing improved chondrogenesis in trochlear versus condylar cartilage defects
after bone marrow stimulation in rabbits. This may be explained by various parameters
affecting the degree of cartilage regeneration at different implant locations, such as the
animal model, follow-up period and rehabilitation protocol.
Different outcome measures such as macroscopic and histological evaluation, semi-
quantitative macroscopical and histological evaluation using scoring systems, histomor-
phometry, PCR and biochemical assays were used to assess the regenerative potential
of implanting biomaterials. In this systematic review and meta-analysis, only data from
semi-quantitative histological scoring systems were used as outcome measure. We chose
to use these data as most authors presented their results by this method and it allows
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quantitative comparison of different studies in a meta-analysis. Various histological
scoring systems have been used by the authors of included studies, such as the O’Driscoll,
Pineda, Wakitani and ICRS scoring system, which were also reviewed by Rutgers et al.
(2010). Depending on the histological scoring system, parameters such as cell morphology,
matrix staining, surface regularity, structural integrity, defect filling and the restoration
of the subchondral bone were evaluated. A limitation of this outcome measure is that
the specific topics addressed in the scoring systems greatly differ, i.e., some studies focus
on the regeneration of cartilage only, cartilage as well as subchondral bone, or include a
biomaterial component (e.g., scoring degradation of the implant). Other outcomemeasures
including macroscopic evaluation, biochemical analysis and biomechanical aspects of the
tissue may complete the overview of the tissue quality and provide valuable insights in
articular cartilage regeneration, but these outcome measures were only used in a limited
number of studies, and therefore not assessed in this analysis.
The risk of bias assessment provided insights in the quality of the experimental design
of the studies. Most studies scored a low or unknown risk of bias, however, also little
high risk of bias was scored. Low methodological quality (internal validity) may result in
an overestimation or underestimation of the intervention effect (Higgins et al., 2011). In
general, details regarding the randomization procedure were not described. Moreover, an
observation during the risk of bias assessment was that only few studies included in the
systematic review described that power calculations were performed, which is a crucial
aspect in conducting experimental studies to ensure sufficient power of experimental
designs. As a consequence, studiesmay lack sufficient power and thereby run the risk of false
negative results. Due to the poor reporting of the experimental design for themajority of the
studies the assessment of the adequacy of randomization and power calculations, and thus
the assessment of the actual risk of selection bias, was inadequate. However, it may also hold
true that studies were well designed but there was only poor reporting of the experimental
designs (Hooijmans et al., 2012). Most researchers scoring the histology sections were
blinded and sections were randomized. However, when biomaterials are not (completely)
degraded, blinding between biomaterials and empty defects is practically impossible. A
lack of blinding of outcome assessors implies the risk of detection/observer bias (Bello et
al., 2014). Bias may have been introduced by the lack of blinding and randomization and
detracts from the overall validity of the results (Bebarta, Luyten & Heard, 2003; Hirst et al.,
2014). There is a risk that the positive results found are an overestimation of the true effect
of using biomaterials. Introducing standardized protocols such as the golden standard
publication checklist (Hooijmans et al., 2011) or the ARRIVE guidelines (Kilkenny et al.,
2012) may improve reporting of animal studies.
Funnel plots represent the precision of the measured effects, which increases by an
increase in study size. Therefore, for small and large studies scatter will be relatively large
and little, respectively. As a consequence, generally, in the absence of bias the plot resembles
a symmetrical pyramid (a funnel) (Higgins & Green, 2011). An important limitation may
be publication bias, sincemultiple studies were included from the same author and negative
results may not be published. It was described in a study by ter Riet et al. that researchers
themselves estimate that only 50% of the conducted animal experiments are published.
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This problem may be solved by statistical corrections for publication bias (ter Riet et al.,
2012). In our study, the funnel plot did not show asymmetry and therefore did not indicate
the presence of publication bias.
The translational value of animal studies depends on the comparability to the clinical
situation. One of the limitations of the performed animal experiments is the short follow-
up times. The maximum follow-up time was one year, but most studies investigated
cartilage regeneration up to six months. This limits the translational value since clinical
improvements in humans are generally observed up to 1.5–3 years after microfracture
surgery (Hoemann et al., 2010; Van der Linden et al., 2013). Moreover, many variations
were present in the applied animal models, i.e., animal characteristics (species, strain,
sex, age, weight), surgical defects (size, depth and location), applied biomaterials, and
incorporated biologics. A review by Chu, Szczodry & Bruno (2010) extensively reflects on
benefits and limitations of different animal models used in cartilage repair studies. They
state that for humans the volume of a cartilage defect is approximately 550 mm3 and
treatment is required for defects with a surface larger than 10 mm2. Due to the limited joint
size of many animals, larger animal models such as minipig, goat and horse therefore offer
superior translational value than smaller animals such as rats, rabbits and dogs. However,
all studies contained defect volumes smaller than 550 mm3 and only few studies had
defects surfaces larger than 10 mm2. Additionally, cartilage thickness differs among various
species, with goat, rabbit, minipig and dogs having thinner cartilage than humans. Another
drawback for some animal models is the large endogenous repair potential. In humans,
untreated defects show little to no regeneration while rabbits display a large regenerative
potential, limiting clinical translation. Dog, goat, minipig and horse do not have this
large endogenous repair and the use of these animals may therefore be favorable. The
maturity of the animals is of great importance when designing animal experiments since
open growth plates can impede with the applied treatment. Animal species are skeletally
mature at different ages; i.e., rabbits at the age of 16–39 weeks, pigs at 42–52 weeks, dogs
at 12–24 months, sheep and goat at 24–36 months and horses at 60–72 months (Ahern
et al., 2009; Chu, Szczodry & Bruno, 2010). In this study we did not group studies based
on animal maturity. In addition to clinical relevance, other reasons to select an animal
model are related to logistical, financial, and ethical considerations. A systematic review
conducted by Ahern et al. (2009) investigated the strengths and shortcomings of different
animal models and compared these with common clinical lesions in clinical studies. They
remarked that smaller animal models are often used due to feasibility, while large animal
models may more closely resemble humans. However, no differences were found between
animal models in this systematic review and meta-analysis, which may be explained by
various parameters affecting the degree of cartilage regeneration such as implant location,
defect size, follow-up period and rehabilitation protocol.
In this systematic review and meta-analysis the efficacy of cartilage regeneration using
acellular biomaterials was compared to the natural healing response of defects treated
with microfracture surgery and subchondral drilling. The risk of bias assessment indicated
poor reporting in animal studies, which may be improved in future animal studies.
Moreover, to improve the translation towards clinical trials animal experiments should
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be comparable to the clinical situation. As described in this systematic review a relatively
high level of heterogeneity exists between studies related to the animal model, surgery
and follow-up, with a need to resemble current clinical settings more closely. In this study
we only addressed bone marrow stimulating techniques (microfracture and subchondral
drilling) and subsequently the incorporation of biomaterials, but also the regeneration of
partial thickness cartilage defects may be beneficial to prevent progression to full-thickness
cartilage defects, limit the progression towards osteoarthritis and improve quality of life in
patients. Inmany studies also cell-laden biomaterials have been implanted and the beneficial
effect of cellular biomaterials versus acellular biomaterials and the natural healing response
has been studied. Although acellular biomaterials offer various advantageous properties
over cellular biomaterials such as no donor-site, no cell culture, off the shelf availability,
less regulatory issues, and application of one-stage surgical procedures (Brouwer et al.,
2011; Efe et al., 2012), studying the additive value of cellular biomaterials may aid further
improvement of marrow stimulating techniques.
CONCLUSION
The systematic review andmeta-analysis resulted in a structured, thorough and transparent
overview of literature related to the current evidence for the efficacy of cartilage regeneration
using acellular biomaterials implanted after microfracturing in animal models. Cartilage
regeneration is more effective by implantation of acellular biomaterials in microfracture
defects compared to microfracturing alone. The efficacy is further improved by the
incorporation of biologics.
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